ArticlePharmacotherapy2020

Complementary Use of U.S. FDA's Adverse Event Reporting System and Sentinel System to Characterize Direct Oral Anticoagulants-Associated Cutaneous Small Vessel Vasculitis.

Mohamed Mohamoud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.